Neuropharmacological modulation of cognitive deficits after brain damage

Current Opinion in Neurology

Volumn 18, Issue 6, 2005, Pages 675-680

  Parton, Andrew ^a   Coulthard, Elizabeth ^b   Husain, Masud ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Cognitive function; Neuropharmacology; Stroke; Traumatic brain injury

Indexed keywords

ALCOHOL; BROMOCRIPTINE; CAFFEINE; CHOLINESTERASE INHIBITOR; DIZOCILPINE; DONEPEZIL; GALANTAMINE; GUANFACINE; METHANESULFONYL FLUORIDE; METHYLPHENIDATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; ZOLPIDEM;

APHASIA; BRAIN FUNCTION; BRAIN INJURY; BRAIN REGION; CLINICAL TRIAL; COGNITIVE DEFECT; COMPREHENSION; DRUG EFFICACY; HUMAN; HYPERTENSION; NERVE CELL NECROSIS; NEUROLOGIC EXAMINATION; NONHUMAN; OUTCOMES RESEARCH; REVIEW; STATISTICAL SIGNIFICANCE; STROKE; TASK PERFORMANCE; WORKING MEMORY;

EID: 27944501103     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000189872.54245.13     Document Type: Review

References (39)

1. Salmond CH, Sahakian BJ. Cognitive outcome in traumatic brain injury survivors. Curr Opin Crit Care 2005; 11:111-116. This is a review of recent studies of the cognitive and psychiatric consequences of traumatic brain injury.
2. Nys GM, van Zandvoort MJ, de Kort PL, et al. The prognostic value of domain-specific cognitive abilities in acute first-ever stroke. Neurology 2005; 64:821-827. This is detailed investigation of 168 patients demonstrating long-term cognitive impairment in approximately one-third of stroke survivors.
3. Parton A, Malhotra P, Husain M. Hemispatial neglect. J Neurol Neurosurg Psychiatry 2004; 75:13-21. A clinically orientated review discussing the diagnosis and potential treatments for visual neglect.
4. Hellawell DJ, Taylor RT, Pentland B. Cognitive and psychosocial outcome following moderate or severe traumatic brain injury. Brain Inj 1999; 13:489-504.
5. Egelko S, Simon D, Riley E, et al. First year after stroke: tracking cognitive and affective deficits. Arch Phys Med Rehabil 1989; 70:297-302.
6. Bak T. Aphasia. Advances in Clinical Neuroscience and Rehabilitation 2005; 5:30-32.
7. Salmond CH, Menon DK, Chatfield DA, et al. Deficits in decision-making in head injury survivors. J Neurotrauma 2005; 22:613-622.
8. Dobkin BH. Clinical practice. Rehabilitation after stroke. N Engl J Med 2005; 352:1677-1684.
9. Breitenstein C, Wailke S, Bushuven S, et al. D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology 2004; 29:1704-1714.
10. Knecht S, Breitenstein C, Bushuven S, et al. Levodopa: faster and better word learning in normal humans. Ann Neurol 2004; 56:20-26. This study in normal subjects demonstrated that levodopa can significantly enhance the speed, overall success, and long-term retention of novel word learning.
11. Feldman RS, Meyer JS, Quenzer LF. Principles of neuropsychopharmacology. Sunderland: Sinauer Associates; 1997.
12. Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 244:798-800.
13. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13:171-182.
14. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79:1431-1568.
15. Morris GF, Bullock R, Marshall SB, et al. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg 1999; 91:737-743.
16. Davis SM, Lees KR, Albers GW, et al. Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 2000; 31:347-354.
17. Albers GW, Clark WM, Atkinson RP, et al. Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke. Stroke 1999; 30:508-513.
18. Albers GW, Goldstein LB, Hall D, Lesko LM. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA 2001; 286:2673-2682.
19. Sacco RL, DeRosa JT, Haley EC Jr, et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 2001; 285:1719-1728.
20. Dash PK, Moore AN, Moody MR, et al. Post-trauma administration of caffeine plus ethanol reduces contusion volume and improves working memory in rats. J Neurotrauma 2004; 21:1573-1583.
21. Zhao X, Liu SJ, Zhang J, et al. Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats. Stroke 2005; 36:129-134.
22. Belayev L, Khoutorova L, Zhang Y, et al. Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats. Brain Res 2004; 1008:278-283.
23. Piriyawat P, Labiche LA, Burgin WS, et al. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke. Stroke 2003; 34:1242-1245.
24. Aronowski J, Strong R, Shirzadi A, Grotta JC. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke 2003; 34:1246-1251.
25. Biegon A, Fry PA, Paden CM, et al. Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci USA 2004; 101:5117-5122. This extremely important study demonstrated that increases in the neurotransmitter glutamate after brain injury (thought to mediate delayed neuronal death) are only transitory and followed by a sustained decrease. The authors propose that stimulation of NMDA receptors may help to preserve cognitive function.
26. Borlongan CV, Sumaya IC, Moss DE. Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats. Brain Res 2005; 1038:50-58. This interesting study showed that methanesulfonyl fluoride, possibly by preserving a functional cholinergic system, attenuated stroke-induced deficits in a simple learning and memory task.
27. Kline AE, Massucci JL, Ma X, et al. Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma. J Neurotrauma 2004; 21:1712-1722. This important study showed that TBI-induced oxidative stress is attenuated by acute bromocriptine treatment leading to improved cognitive outcome and greater preservation of hippocampal neurons.
28. Borlongan CV, Yu G, Matsukawa N, et al. Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke. Life Sci 2005; 76:1503-1512.
29. Zhao CS, Puurunen K, Schallert T, et al. Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats. Behav Brain Res 2005; 156:85-94.
30. Berthier ML, Hinojosa J, Martin Mdel C, Fernandez I. Open-label study of donepezil in chronic post stroke aphasia. Neurology 2003; 60:1218-1219.
31. Zhang L, Plotkin RC, Wang G, et al. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 2004; 85:1050-1055.
32. Walker W, Seel R, Gibellato M, et al. The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes. Brain Inj 2004; 18:739-750.
33. Granger CV, Hamilton BB, Linacre JM, et al. Performance profiles of the functional independence measure. Am J Phys Med Rehabil 1993; 72:84-89.
34. Whyte J, Hart T, Vaccaro M, et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil 2004; 83:401-420.
35. Lee H, Kim SW, Kim JM, et al. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol 2005; 20:97-104.
36. Husain M, Rorden C. Non-spatially lateralized mechanisms in hemispatial neglect. Nat Rev Neurosci 2003; 4:26-36.
37. Robertson IH, Mattingley JB, Rorden C, Driver J. Phasic alerting of neglect patients overcomes their spatial deficit in visual awareness. Nature 1998; 395:169-172.
38. Malhotra PA, Parton AD, Greenwood R, Husain M. Noradrenergic modulation of space exploration in visual neglect. Ann Neurol (in press).
39. Cohen L, Chaaban B, Habert MO. Transient improvement of aphasia with zolpidem. N Engl J Med 2004; 350:949-950. This single case study showed that zolpidem may improve aphasia in patients with preserved cortical structures.